Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch

J. Mužíková, A. Srbová, P. Svačinová,

. 2017 ; 22 (8) : 964-971. [pub] 20160112

Language English Country England, Great Britain

Document type Journal Article

This paper deals with a study of the novel coprocessed dry binder Combilac®, which contains 70% of α-lactose monohydrate, 20% of microcrystalline cellulose and 10% of native corn starch. These tests include flow properties, compressibility, lubricant sensitivity, tensile strength and disintegration time of tablets. Compressibility is evaluated by means of the energy profile of compression process, test of stress relaxation and tablet strength. The above-mentioned parameters are also evaluated in the physical mixture of α-lactose monohydrate, microcrystalline cellulose and native corn starch and compared with Combilac. Combilac shows much better flowability than the physical mixture of the used dry binders. Its compressibility is better, tablets possess a higher tensile strength. Neither Combilac, nor the physical mixture can be compressed without lubricants due to high friction and sticking to the matrix. Combilac has a higher lubricant sensitivity than the physical mixture of the dry binders. Disintegration time of Combilac tablets is comparable with the disintegration time of tablets made from the physical mixture.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025398
003      
CZ-PrNML
005      
20180718101840.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10837450.2015.1131717 $2 doi
035    __
$a (PubMed)26758475
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Mužíková, Jitka $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
245    12
$a A study of a novel coprocessed dry binder composed of α-lactose monohydrate, microcrystalline cellulose and corn starch / $c J. Mužíková, A. Srbová, P. Svačinová,
520    9_
$a This paper deals with a study of the novel coprocessed dry binder Combilac®, which contains 70% of α-lactose monohydrate, 20% of microcrystalline cellulose and 10% of native corn starch. These tests include flow properties, compressibility, lubricant sensitivity, tensile strength and disintegration time of tablets. Compressibility is evaluated by means of the energy profile of compression process, test of stress relaxation and tablet strength. The above-mentioned parameters are also evaluated in the physical mixture of α-lactose monohydrate, microcrystalline cellulose and native corn starch and compared with Combilac. Combilac shows much better flowability than the physical mixture of the used dry binders. Its compressibility is better, tablets possess a higher tensile strength. Neither Combilac, nor the physical mixture can be compressed without lubricants due to high friction and sticking to the matrix. Combilac has a higher lubricant sensitivity than the physical mixture of the dry binders. Disintegration time of Combilac tablets is comparable with the disintegration time of tablets made from the physical mixture.
650    _2
$a celulosa $7 D002482
650    _2
$a pomocné látky $7 D005079
650    _2
$a laktosa $7 D007785
650    _2
$a škrob $7 D013213
650    _2
$a tablety $7 D013607
650    12
$a farmaceutická technologie $7 D013678
650    _2
$a pevnost v tahu $7 D013718
650    12
$a kukuřice setá $7 D003313
655    _2
$a časopisecké články $7 D016428
700    1_
$a Srbová, Alena $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
700    1_
$a Svačinová, Petra $u a Department of Pharmaceutical Technology , Charles University in Prague, Faculty of Pharmacy in Hradec Králové , Czech Republic.
773    0_
$w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 22, č. 8 (2017), s. 964-971
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26758475 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718102140 $b ABA008
999    __
$a ok $b bmc $g 1317529 $s 1022319
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 22 $c 8 $d 964-971 $e 20160112 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...